Debenture Agreements in the Pharmaceuticals Industry

107 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3 to Debenture between the Company and Berique Labs LLC
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2020
First Amending Agreement to Debenture, entered into on October 9, 2024, by and among Universal Hemp, LLC, Universal Hemp II, LLC, Universal Hemp Canada ULC and Canopy USA, LLC (as...
Debenture Agreements
Acreage Holdings, Inc.
Pharmaceuticals
2024
Form of Convertible Debenture Certificate
Debenture Agreements
Canopy Growth Corp
Pharmaceuticals
2024
Form of Unsecured Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amended and Restated Debenture dated December 29, 2023, by and between the Company and Navy Capital Green Co-Invest Fund, LLC
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Third Amended and Restated Debenture dated December 29, 2023, by and between the Company and Navy Capital Green Fund, LP
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2024
Form of Unsecured Debenture
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Navy Capital Green Fund LP in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
AMENDED AND RESTATED UNSECURED DEBENTURE
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Tribeca Investment Partners in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Tribeca Investment Partners in the principal amount of $500,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Ian Whitmore in the principal amount of $250,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Amended and Restated Unsecured Debenture dated May 31, 2023, issued to Graham Saunders in the principal amount of $250,000.00
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2023
Form of Original Issue Discount Secured Senior Convertible Debenture
Debenture Agreements
NovaBay Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Form of Debenture, dated December 19, 2022, issued by Body and Mind Inc. to each of BAM I, A Series of Bengal Catalyst Fund SPV, LP, Mindset Value Fund LP and Mindset Value...
Debenture Agreements
BODY & MIND INC.
Pharmaceuticals
GA
2022
Convertible Debenture, dated November 14, 2022, issued by Charlottes Web Holdings, Inc
Debenture Agreements
Charlotte's Web Holdings, Inc.
Pharmaceuticals
2022
Second Amended and Restated Convertible Debenture, dated September 15, 2022, issued to Navy Capital Green Co-Invest Fund, LLC
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2022
Second Amended and Restated Convertible Debenture, dated September 15, 2022, issued to Navy Capital Green Fund, LP
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2022
Form of Debenture
Debenture Agreements
Lowell Farms Inc.
Pharmaceuticals
DE
2022
Form of 8.0% Senior Unsecured Debenture
Debenture Agreements
iANTHUS CAPITAL HOLDINGS, INC.
Pharmaceuticals
NY
2022
Form of 8.0% Senior Secured Debenture
Debenture Agreements
iANTHUS CAPITAL HOLDINGS, INC.
Pharmaceuticals
NY
2022
Unsecured Debenture Agreement dated June 24, 2022 by and among the Company, as guarantor, iAnthus Capital Management, LLC and the holders of all of the Companys 8% unsecured...
Debenture Agreements
iANTHUS CAPITAL HOLDINGS, INC.
Pharmaceuticals
NY
2022
Form of Warrant issued in connection with the November 2021 Debenture Offering
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
2022
Form of Debenture issued in connection with the November 2021 Debenture Offering
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
FL
2022
Cancellation and Satisfaction of Debenture Agreement by and between Bespoke Extracts, Inc. and Berique Labs, LLC
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2021
Amendment No. 6 to Debenture between the Company and Berique Labs LLC
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2021
Amendment No. 6 to Debenture between the Company and The Vantage Group Ltd
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2021
Amending Agreement to the Restructuring Support Agreement dated June 15, 2021 by and among the Company, the Secured Lenders and the Consenting Debenture Holders
Debenture Agreements
iANTHUS CAPITAL HOLDINGS, INC.
Pharmaceuticals
FL
2021
Amended and Restated Convertible Debenture, dated April 19, 2021, issued to Darling Capital, LLC in the principal amount of $599,101
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Amended and Restated Convertible Debenture, dated April 15, 2021, issued to Navy Capital Green Co-Invest Fund, LLC in the principal amount of $4,504,457
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Amended and Restated Convertible Debenture, dated April 15, 2021, issued to Navy Capital Green Fund, LP in the principal amount of $1,126,114
Debenture Agreements
CLS Holdings USA, Inc.
Pharmaceuticals
NV
2021
Amendment No. 5 to Debenture between the Company and Berique Labs LLC
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2021
Amendment No. 5 to Debenture between the Company and The Vantage Group Ltd
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2021
Amendment No. 4 to Debenture between the Company and Berique Labs LLC
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2021
Amendment No. 4 to Debenture between the Company and The Vantage Group Ltd
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2021
Amendment No. 3 to Debenture between the Company and The Vantage Group Ltd
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2020
Debenture, dated as of September 23, 2020, issued by Universal Hemp, LLC to 11065220 Canada Inc
Debenture Agreements
Acreage Holdings, Inc.
Pharmaceuticals
NY
2020
Form of Allonge Amendment No. 1 to Second Amended and Restated 10% Senior Secured Convertible Debenture Due April 21, 2021 (included as Exhibit A to Exhibit 10.1)
Debenture Agreements
MYnd Analytics, Inc.
Pharmaceuticals
NY
2020
Debenture, dated as of September 23, 2020, issued by Universal Hemp, LLC to 11065220 Canada Inc
Debenture Agreements
Canopy Growth Corp
Pharmaceuticals
NY
2020
Amendment No. 2 to Debenture
Debenture Agreements
Bespoke Extracts, Inc.
Pharmaceuticals
2020